China's Strong Economic Growth and Healthcare Investments Generate Success for CPhI

Amsterdam (ots/PRNewswire) -

China's 'Five Year Plan' underway as attendance at 2013 show
rockets

CPhI and UBM Live today announced that this year's recent CPhI
China 2013, which took place on 25th-27th June at the Shanghai New
International Expo Centre, was the most successful exhibition to
date.

(Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

Attendance rates far exceeded expectation and CPhI and P-MEC
China, alongside co-located events BioPh, ICSE, InnoPack, hosted a
record breaking more than 2,400 companies, both local and
international, and attracted more than 30,000 visitors from 133
countries throughout the world.

The 13th consecutive event was the foremost meeting point and
networking opportunity for senior Chinese pharma professionals and
international pharmaceutical suppliers and buyers.

In response to the implementation of China's 'five year plan',
CPhI China 2013 saw a strong focus on research and development with
LABWorld, BioPharma and ICSE all contained in one hall, mirroring
China's continued commitment to this area and reflecting its
exemplary position in the pharmaceutical world.

R&D investments in China have been at a high throughout 2013- it
has been estimated that growth in investment within this area matches
that of the USA. The [12th] 'Five-Year Plan', implemented by the
Chinese government targets pharmaceutical R&D as a key initiative,
with financial and beneficial incentives being offered in order to
encourage R&D activities within the country. These include exemption
from import customs duty on R&D equipment and a reduced income tax
rate. In light of this, the R&D focus at CPhI China 2013 provided an
informative update on the efforts being made by the government in
facilitating innovation within the country.

On-site at CPhI China 2013, the "China and World" Medical Forum
proved highly insightful and valuable for attendees. Having received
substantial support from a vibrant speaker team of government and
leading pharmaceutical companies, the forum showcased hot topic
seminars and conferences. These covered the latest policies and
regulations within the pharmaceutical industry and the practical
applications of new technology. Furthermore, the Buyer Sourcing
Event, with more than 60 buyers, 280 sessions and over 90% successful
match rate, has provided a catalyst for increased business
connections in the region.

Chris Kilbee, CPhI Pharma Group Director at UBM Live commented,
"The Chinese pharmaceutical industry is now the third largest in the
world and is ever growing -- it is predicted to expand at the annual
rate of 12% from 2013 to 2020. Having witnessed a shift in focus to
R&D by China, CPhI China 2013 was designed to reflect these
widespread changes. The event was undoubtedly a success for both UBM
Live, CCMHPIE and our attendees and, consequently, over 40% of
exhibitors present have already registered for next year. This result
shows that CPhI China is now at the centre of pharmaceutical business
connections within the region."

CPhI 2014 will return alongside co-located events ICSE, BioPh,
P-MEC, InnoPack and Labworld, on 26th -28th June, 2014 at the
Shanghai New International Expo Centre. The exhibition will increase
its scale and, reiterating the importance of R&D in China as CPhI
China 2014 will focus on biopharmaceutical R&D with 'BioPh China' and
'ICSE China' making up an integral part of the exhibition. A further
main focus for next year will be natural extracts in which exhibiting
companies will occupy more than one hall.

The UBM Live annual schedule of Pharmaceutical events also
includes CPhI Worldwide, ICSE, P-MEC Europe and InnoPack ; CPhI and
P-MEC India (03-05 December, 2013 at the Bombay Exhibition Centre in
Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan ; CPhI Russia
and IPhEB (16-17 April, 2014 in St Petersburg, Russia); CPhI, P-MEC
and Innopack South East Asia (20-22 May, 2014 in Jakarta, Indonesia);
CPhI Istanbul (4-6 June, 2014, Turkey)

http://www.cphi-china.com

The UBM Live annual schedule of Pharmaceutical events also
includes CPhI, ICSE and BioPh South America (06-08 August, 2013 at
the Expo Center Norte in Sao Paulo, Brazil); CPhI Worldwide, ICSE,
P-MEC Europe and InnoPack (22-24 October, 2012 at Messe Frankfurt,
Germany; CPhI and P-MEC India (03-05 December, 2013 at the Bombay
Exhibition Centre in Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec
Japan ; CPhI Russia and IPhEB (16-17 April, 2014); CPhI, P-MEC and
Innopack SE Asia (20-22 May, 2014 in Jakarta, Indonesia); CPhI,
P-MEC, ISCE, InnoPack Istanbul (4-6 June 1014 in Istanbul) CPhI,
P-MEC, ICSE, InnoPack and BioPh China (26-28 June 2014 in Shaghai).

About CPhI

CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage.
Through exhibitions, conferences and online communities, CPhI brings
together more than 100,000 pharmaceutical professionals each year to
network, identify business opportunities and expand the global
market. CPhI hosts events in Europe, China, India, Japan, Southeast
Asia, Russia and South America co-located with ICSE for contract
services, P-MEC for machinery, equipment & technology, InnoPack for
pharmaceutical packaging and BioPh for biopharma. CPhI provides an
online buyer & supplier directory at CPhI-Online.com and hosts a
global community with news and analysis at PharmaEvolution.com.

For more information visit: http://www.cphi.com

About UBM Live

UBM Live connects people and creates opportunities for companies
across five continents to develop new business, meet customers,
launch new products, promote their brands, and expand their market.
Through premier brands such as TFM&A, Internet World, IFSEC, MD&M,
CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM
Live exhibitions, conferences, awards programs, publications,
Websites, and training and certification programs are an integral
part of the marketing plans of companies across more than 20 industry
sectors.

For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44-(0)207-203-6745 / 6740
E: a.heeley@defacto.com / t.jervis@defacto.com

Photo:
http://photos.prnewswire.com/prnh/20130723/629764-a

ots Originaltext: UBM Live
Im Internet recherchierbar: http://www.presseportal.de